entertainment -WSS

entertainment

author：fashion 2025-08-25 07:27:46 - browse：98

Andrew Trister, an oncologist and veteran of big technology companies and research, is Verily's new chief scientific officer.

As Verily aims to get on track, the Alphabet life science company has hired Andrew Trister, an oncologist and veteran of big technology companies and research, as its new chief scientific officer.

Trister will lead Verily’s population health initiatives, including public health solutions like the company’s ongoing work to combat disease-carrying mosquito populations and a program that helps wastewater treatment plants monitor for pathogens. He will also consult across Verily’s diverse projects.

Trister’s focus on public health will build on his recent role as a deputy director at the Bill and Melinda Gates Foundation, where he led digital health, including a project to build tech infrastructure to help with malaria testing. Trister also led the foundation’s Covid-19 response. In 2016, he was an early health hire at Apple. There, he worked on programs like a heart health study with Janssen, an app to promote healthy habits with Aetna, and research into digital biomarkers for Alzheimer’s disease with Eli Lilly and Evidation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： What is microchimerism and how does it affect maternal health?

knowledge

WSS

Readout LOUD podcast: ESMO highlights & Roivant's big deal

After Sarepta trial failure, Duchenne families brace for more debate

Medicare must police algorithms in Medicare Advantage, Dems say

Travis Kelce and the trap of celebrity vaccine endorsements

H5N1 bird flu virus started spreading in cows in Texas in December

Infant mortality in U.S. rose last year for first time in decades: CDC

hotspot

entertainment

knowledge

In age of alternative facts, a scholarly course on calling out crap

MultiPlan and major insurers sued for alleged medical price

Supreme Court strikes down use of affirmative action

Cholera vaccine supply gets boost as demand surges globally

Apple is now the first public company to be valued at $3 trillion

Key Senate committee drafts bipartisan bill to stem drug shortages

How one medical school became remarkably diverse

Coloradans with cystic fibrosis could lose access to Trikafta

In Memoriam: Notable people who died in 2023

Key Senate panel to consider PBM, drug pricing reform package

focus

The health care issue Democrats can’t solve: hospital reform

After traumatic brain injury, life support decisions can use more time

Infant mortality in U.S. rose last year for first time in decades: CDC

Medical bills so high, Medicare adding extra digits to claim forms

Diversity in clinical trials starts with building trust, experts say

Key Senate panel to consider PBM, drug pricing reform package

focus

focus

knowledge

hotspot